BioNTech's Series A Round

BioNTech raised a round of funding on January 04, 2018.

BioNTech is developing the next generation of personalized immunotherapies to help revolutionize the treatment of people with cancer and other debilitating diseases.…

Articles about BioNTech's Series A Round: